Facebook Instagram Twitter RSS Feed PodBean Back to top on side

International Cooperation

EC public consultation on the Orphan and Paediatric Regulations

17. 6. 2021 | 376 visits

If you are interested in sharing your views and experience on the main obstacles you may be facing concerning treatments for rare diseases and children, on possible ways to overcome these obstacles and on how to make the current legislation future-proof, the European Commission (EC) (as part of its review of the Orphan and Paediatric Regulations announced in 2020) has launched a public consultation for stakeholders such as patient organisations, healthcare professionals and providers, researchers, academics and representatives of the pharmaceutical industry, as well as members of the general public.

The public consultation is currently accepting inputs as a questionnaire and will close on July 30, 2021.


More information: https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12767-Medicines-for-children-&-rare-diseases-updated-rules/public-consultation_en